The Abuse Potential of Remoxy<sup>®</sup>, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release OxycodoneBeatrice Setnik, Lynn R. Webster, Carl L. Roland et al.|Pain Medicine|2011Cited by 42
Opioid Titration and Conversion in Patients Receiving Morphine Sulfate and Naltrexone Hydrochloride Extended Release CapsulesLynn R. Webster, Beatrice Setnik, David Morris et al.|Postgraduate Medicine|2011Cited by 8
Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxideVeeraindar Goli, Eric Carter, Lynn R. Webster et al.|Harm Reduction Journal|2012Cited by 5